LHX2 mediates the breakdown of the β-catenin/TCF4 complex and induces the expression of multiple Wnt inhibitors, leading to a Wnt/β-catenin signaling pathway that inhibits HCC cell growth. Here, TCF4 is linked to hepatocellular carcinoma.